Publications by authors named "Allyson Price"

Claim this Profile
S
Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclax.
Maria Tariq Siddiqui, Allyson Price, Alessandra Ferrajoli, Gautam Borthakur

Leuk Res Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker Jeopardy.
Sandra E Kurtin, Alyssa Henglefelt, Allyson Price

J Adv Pract Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Advanced Practitioner's Role in Treating Patients With Hematologic Malignancies: Highlights From SOHO 2020.
Allyson Price

J Adv Pract Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Report of Sorafenib in Patients With Acute Myeloid Leukemia Harboring Non-Canonical Mutations.
Naval Daver, Allyson Price, Christopher B Benton, Keyur Patel, Weiguo Zhang

Front Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia.
Iman Abou Dalle, Ahmad Ghorab, Keyur Patel, Xuemei Wang, Hyunsoo Hwang, Allyson Price

Blood Cancer J· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Use of Newly Approved Agents for Acute Myeloid Leukemia.
Nancy M Nix, Allyson Price

J Adv Pract Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of the Advanced Practitioner in Enhancing Outcomes.
Nancy M Nix, Allyson Price

J Adv Pract Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis